Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Since people here keep bringing up EUA for B, I thought some might find the EUA doc for Tocilizumab an interesting read.

Of note, the drug appears to have been in 4 different studies (clinical) between April 2020 and Jan 2021'ish with total participant subjects of 5,605.

This is for the IV monoclonal antibody, with similar delivery (IV) and endpoints as Brilacidin... so I thought the read was an interesting one.

https://www.fda.gov/media/150748/download